Movatterモバイル変換

[0]ホーム
URL:

GB1388786A - Integral solid gel-lattice dosage form of high-moisture content - Google Patents

Integral solid gel-lattice dosage form of high-moisture content

Info

Publication number
GB1388786A
GB1388786AGB1130873AGB1130873AGB1388786AGB 1388786 AGB1388786 AGB 1388786AGB 1130873 AGB1130873 AGB 1130873AGB 1130873 AGB1130873 AGB 1130873AGB 1388786 AGB1388786 AGB 1388786A
Authority
GB
United Kingdom
Prior art keywords
lattice
gel
cellulose
histamine
active compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1130873A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Catalent Pharma Solutions Inc
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions IncfiledCriticalCatalent Pharma Solutions Inc
Publication of GB1388786ApublicationCriticalpatent/GB1388786A/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

1388786 Gel dosage unit R P SCHERER CORP 8 March 1973 [3 April 1972] 11308/73 Heading A5B Pharmaceutical dosage units consist of (a) a stable, inert, rigid, macromolecular gel-lattice which has been prepared by solidifying a melt and (b) within the interstices of the lattice a composition comprising (i) a pharmaceutically active compound and (ii) 4-20% of water based on the total weight of the dosage unit. The gel lattice may be gelatin, casein, collagen, albumin, soya protein, pecin, agar, acacia, karays, tragacanth, Irish moss, algins, alginates, guar, Iceland moss, modified starch, methyl cellulose, carboxymethyl cellulose, hydroxypropyl cellulose, sodium cellulose sulphate, polyvinylpyrrolidone, polyacrylic acid, copoly (ethylene/ maleic acid), polyvinyl alcohol. The pharmaceutically active compound may be: diphenhydramine hydrochloride (anti-histamine-somnifacient), phenolphthalein, (laxative), peppermintspearmint (breath freshner), ephedrine sulphate (decongestant), chloral hydrate (sedativesoporific), methorphan/cough remedy), isoproterenol hydrochloride (bronchodilator), dimenhydrinate (anti - nauseant), chlorpheniramine maleate (anti histamine).
GB1130873A1972-04-031973-03-08Integral solid gel-lattice dosage form of high-moisture contentExpiredGB1388786A (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US24083472A1972-04-031972-04-03

Publications (1)

Publication NumberPublication Date
GB1388786Atrue GB1388786A (en)1975-03-26

Family

ID=22908131

Family Applications (1)

Application NumberTitlePriority DateFiling Date
GB1130873AExpiredGB1388786A (en)1972-04-031973-03-08Integral solid gel-lattice dosage form of high-moisture content

Country Status (5)

CountryLink
JP (1)JPS5116926B2 (en)
CA (1)CA1041905A (en)
DE (1)DE2316242A1 (en)
FR (1)FR2179044B1 (en)
GB (1)GB1388786A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU577213B2 (en)*1985-12-191988-09-15Capsoid Pharma GmbhProcess for producing shapes for administering individual doses
US4801460A (en)*1986-04-111989-01-31Basf AktiengesellschaftPreparation of solid pharmaceutical forms
US5525351A (en)*1989-11-071996-06-11Dam; AndersNicotine containing stimulant unit
RU2108099C1 (en)*1989-11-071998-04-10Дам АндерсSaliva-soluble preparation for giving up tobacco smoking
WO1999017744A1 (en)*1997-10-071999-04-15Fuisz Technologies Ltd.Immediate release drug delivery forms
US6013280A (en)*1997-10-072000-01-11Fuisz Technologies Ltd.Immediate release dosage forms containing microspheres
US6027746A (en)*1997-04-232000-02-22Warner-Lambert CompanyChewable soft gelatin-encapsulated pharmaceutical adsorbates
US6221368B1 (en)1996-09-132001-04-24Basf AktiengesellschaftProcess for producing solid dosage forms by extrusion
WO2006125857A1 (en)*2005-05-262006-11-30Mika Tapio ReijonenComposition and manufacturing process of cetraria islandica based polymer blend
WO2009124763A3 (en)*2008-04-102010-04-01Biophil S.R.L.Dermal patch comprising chondrus crispus extract

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
YU43437B (en)*1976-05-051989-08-31Lowey HansProcess for obtaining tablets containing an active component with long lasting effect
IE45770B1 (en)*1976-10-061982-11-17Wyeth John & Brother LtdPharmaceutical dosage forms
IT1090710B (en)*1976-12-011985-06-26Merck & Co Inc IMPROVEMENT IN COMPOSITIONS FOR DRESSING SALADS AND SIMILAR
FR2515035A1 (en)*1981-10-261983-04-29Rhone Poulenc Sante NEW SOLID GALENIC FORM FOR ORAL ADMINISTRATION AND METHOD OF MANUFACTURING THE SAME
US5229164A (en)*1985-12-191993-07-20Capsoid Pharma GmbhProcess for producing individually dosed administration forms
DE4226753A1 (en)*1992-08-131994-02-17Basf Ag Preparations containing active substances in the form of solid particles
US5458879A (en)*1994-03-031995-10-17The Procter & Gamble CompanyOral vehicle compositions
DE4446380A1 (en)*1994-07-051996-01-11Lohmann Therapie Syst Lts Hydrogel for the application of therapeutic and / or cosmetic agents to the skin
FR2725624B1 (en)*1994-10-141997-01-17Jouveinal Inst Rech PROCESS FOR THE PREPARATION OF CONTROLLED RELEASE PHARMACEUTICAL FORMS
GB9626152D0 (en)*1996-12-171997-02-05Cehmcolloids LtdEncapsulation
CA2309819A1 (en)*1997-11-121999-05-20The Dow Chemical CompanyA process for making a free-flowing, dust-free, cold water dispersible, edible, film-coating composition
AU8621398A (en)*1998-01-121999-07-26Buhler AgMethod and device for capsulating active ingredients

Cited By (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU577213B2 (en)*1985-12-191988-09-15Capsoid Pharma GmbhProcess for producing shapes for administering individual doses
US4801460A (en)*1986-04-111989-01-31Basf AktiengesellschaftPreparation of solid pharmaceutical forms
AU587897B2 (en)*1986-04-111989-08-31Basf AktiengesellschaftPreparation of solid pharmaceutical forms
US6110495A (en)*1989-11-072000-08-29Dam; AndersNicotine containing stimulant unit
US5733574A (en)*1989-11-071998-03-31Dam; AndersNicotine containing stimulant unit
RU2108099C1 (en)*1989-11-071998-04-10Дам АндерсSaliva-soluble preparation for giving up tobacco smoking
US5525351A (en)*1989-11-071996-06-11Dam; AndersNicotine containing stimulant unit
US6221368B1 (en)1996-09-132001-04-24Basf AktiengesellschaftProcess for producing solid dosage forms by extrusion
US6027746A (en)*1997-04-232000-02-22Warner-Lambert CompanyChewable soft gelatin-encapsulated pharmaceutical adsorbates
WO1999017744A1 (en)*1997-10-071999-04-15Fuisz Technologies Ltd.Immediate release drug delivery forms
US6013280A (en)*1997-10-072000-01-11Fuisz Technologies Ltd.Immediate release dosage forms containing microspheres
WO2006125857A1 (en)*2005-05-262006-11-30Mika Tapio ReijonenComposition and manufacturing process of cetraria islandica based polymer blend
WO2009124763A3 (en)*2008-04-102010-04-01Biophil S.R.L.Dermal patch comprising chondrus crispus extract

Also Published As

Publication numberPublication date
CA1041905A (en)1978-11-07
JPS499480A (en)1974-01-28
FR2179044B1 (en)1980-05-23
JPS5116926B2 (en)1976-05-28
FR2179044A1 (en)1973-11-16
DE2316242A1 (en)1973-12-06

Similar Documents

PublicationPublication DateTitle
GB1388786A (en)Integral solid gel-lattice dosage form of high-moisture content
EP0214735B1 (en)Controlled release pharmaceutical composition
US4792452A (en)Controlled release formulation
US4309404A (en)Sustained release pharmaceutical compositions
DE69636223D1 (en) FORMULATION WITH CONTROLLED RELEASE FOR WATER-LIQUEUTIC MEDICAMENTS IN WHICH A DISCHARGE OPENING IS MADE IN SITU
CA2198917A1 (en)Sustained release of peptides from pharmaceutical compositions
HK64893A (en)Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
YU31599A (en)Rapidly releasing and taste-masking pharmaceutical dosage form
CA2433186A1 (en)Delayed release pharmaceutical formulations
ATE229327T1 (en) USE OF REDISPERSIBLE POLYMER POWDERS OR POLYMER GRANULES FOR COATING PHARMACEUTICAL OR AGROCHEMICAL DOSAGE FORMS
KR890016963A (en) Pharmaceutical composition
IE891795L (en)Pharmaceutical compositions for piperidinoalkanol-ibuprofen¹combination
CA2200754A1 (en)Process of making dosage units by wet granulation
CA2374020A1 (en)Simple culture medium and method for preparation thereof
GR1003658B (en)Matrix tablet enabling the prolonged release of trimetazidine after administration by the oral route
IE850286L (en)Piperidine compound.
HU9301672D0 (en)Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
Selzer et al.An experimental study of senecio poisoning in rats
BE903029A (en) NEW PHARMACEUTICAL FORMS ADMINISTRABLE BY NASAL.
DE59401833D1 (en) RETARDIC MICROTABLETTE OF BETA PHENYL PROPIOPHENONE DERIVATIVES
US4428951A (en)Long acting pharmaceutical composition
JPS5726615A (en)Improving method for absorbability of slightly soluble drug
US6740340B1 (en)Pharmaceutical tablets comprising an NSAID and a prostaglandin
CA1225028A (en)Controlled release tablet
IE802033L (en)Dibenzazepine derivatives

Legal Events

DateCodeTitleDescription
PSPatent sealed
PCNPPatent ceased through non-payment of renewal fee
[8]ページ先頭
©2009-2025 Movatter.jp